Categories Uncategorized

Ayahuasca, the Experienced Trauma Therapist

In whatever form it is administered, ayahuasca, a psychoactive brew or tea, has the extensive capacity to illuminate issues underlying addiction, anxiety and also depression. most commonly derived from Banisteriopsis caapi, a vine containing monoamine oxidase inhibitors, and the leaves of Psychotria viridis, ayahuasca often reveals the unprocessed drama that is at the root of these issues. The awareness ayahuasca brings allows deep healing to occur.

Neurological research has shown that trauma affects the emotional brain more than it does the rational brain. While research has not definitively identified the neurophysiological mechanisms through which eye movement desensitization and reprocessing (EMDR) and other body-based trauma healing works, some similarities such as the resolution of past pain and healing imagery indicate that ayahuasca may be activating a set of related natural processes.

Trauma is the emotional and physiological imprint that’s formed by anything that’s too fast, too much or too soon for a person’s nervous system to handle, such as a terrifying incident like rape or a gruesome accident. Trauma’s effects are extensive, manifesting in individuals as a chronic sense of disconnection, either from one’s authentic self, one’s surroundings or others. Unlike with exposure therapy, ayahuasca addresses the trauma’s somatic basis, strengthening a person’s sense of agency and self while also activating internal resources.

Below, we discuss some of the ways in which ayahuasca heals trauma.

  1. Summoning and reliving experiences.

Ayahuasca has the tendency to dig up past traumas in individuals in vivid forms, and it seems to have the capacity to detect unresolved past traumas that might be blocking a person’s growth. These recollections sometimes come up with complete emotions that the individual may have felt at the time.

  1. Bringing awareness into one’s body through the intensification of sensations and emotions.

An important feature of somatic psychotherapy involves exploring an individual’s embodied internal experience in the present time. This triggers intense visceral waves of emotional and somatic information, freeing what’s been long held by a person’s body. This may present in form of freezing cold or heat sensations, yawning, trembling or vomiting. These in-body-based trauma therapies are recognized signs of trauma discharge.

  1. Releasing suppressed memories.

An ayahuasca session can dredge up buried memories from the subconscious. In most cases, this involves childhood trauma. The signs of trauma discharge mentioned above may be observed during this period. This process helps an individual release past memories and the emotions that accompany those memories and instead create room for growth and progress.

  1. Giving rise to new realizations

The cognizance that arises in an ayahuasca ceremony can bring healing perspectives on a person’s past as well as present. This reconnects fragmented facets of a person, thus freeing an individual to choose a more understanding interpretation of the past. The creation of new experiences that go against the limitations imposed by trauma change an individual’s neurological wiring.

In addition to this, ayahuasca generates forgiveness for self and others as well as compassion. While follow-up work is important in the healing process, commitment, emotional wisdom and ego strength will help an individual work through what needs to be released.

From the above, we can clearly see how valuable ayahuasca is to the field of therapy and how it can be effectively used to help alleviate trauma and repair damage caused by trauma. While its techniques may not be as popular as those of somatic trauma therapy or EMDR, they are worth looking into and may be as effective, or even more effective, than these more common approaches.

It is worthwhile for you to watch Cybin Corp. This Canadian-based company focuses on developing pharmaceutical products out of psychedelics the company also has an interest in the functional mushrooms market.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Chris@PNW

Share
Published by
Chris@PNW

Recent Posts

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage

The company targets all current ketamine indications, including anesthesia and pain management. The U.S. is…

4 days ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network

The Kadima Neuropsychiatry Institute acquisition is part of NRx subsidiary HOPE Therapeutics’ model for a…

1 week ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval

Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with Universal Capital. Combined…

3 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition

Kadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network…

3 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Is ‘One to Watch’

NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting multibillion-dollar unmet needs in central…

4 weeks ago

Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform

Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of…

4 weeks ago